acitretin has been researched along with Dermatitis Medicamentosa in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 3 (37.50) | 24.3611 |
| 2020's | 2 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chatterjee, D; Dogra, S; Lad, D; Malhotra, P; Thakur, V; Vinay, K | 1 |
| Aung, PP; Curry, JL; Duke, TC; Glitza Oliva, IC; Ledesma, DA; Marques-Piubelli, ML; Nagarajan, P; Nelson, KC; Prieto, VG; Tetzlaff, MT; Torres-Cabala, CA; Wistuba, II | 1 |
| Chen, C; Nguyen, GH; Wang, BX; Zeng, YP | 1 |
| Plaza, JA; Ravikumar, S; Schieke, SM; Troy, JL; Yu, J | 1 |
| Chirinos, RE; Falo, LD; Geskin, LJ; Pomerantz, RG | 1 |
| Di Lernia, V | 1 |
| Alomar, A; Dalmau, J; Fernández-Figueras, MT; Peramiquel, L; Puig, L; Roé, E | 1 |
| Chang, A; Kuligowski, ME; van de Kerkhof, PC | 1 |
8 other study(ies) available for acitretin and Dermatitis Medicamentosa
| Article | Year |
|---|---|
Ponatinib-induced lamellar ichthyosis-like eruption.
Topics: Acitretin; Aged; Biopsy; Drug Eruptions; Drug Therapy, Combination; Emollients; Exanthema; Female; Glucocorticoids; Humans; Ichthyosis, Lamellar; Imidazoles; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Protein Kinase Inhibitors; Pyridazines; Skin; Treatment Outcome | 2020 |
Hypertrophic lichenoid dermatitis immune-related adverse event during combined immune checkpoint and exportin inhibitor therapy: A diagnostic pitfall for superficially invasive squamous cell carcinoma.
Topics: Acitretin; Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Dermatitis; Drug Eruptions; Drug Therapy, Combination; Exportin 1 Protein; Female; Fluocinonide; Glucocorticoids; Humans; Hypertrophy; Immune Checkpoint Inhibitors; Karyopherins; Keratolytic Agents; Lichenoid Eruptions; Melanoma; Programmed Cell Death 1 Receptor; Receptors, Cytoplasmic and Nuclear; Treatment Outcome; Triamcinolone | 2020 |
Successful treatment of isoniazid-induced lichenoid drug eruption with acitretin.
Topics: Acitretin; Antitubercular Agents; Drug Eruptions; Female; Humans; Isoniazid; Keratolytic Agents; Lichenoid Eruptions; Middle Aged; Tuberculosis, Meningeal | 2018 |
Targeting the adnexal epithelium: an unusual case of syringometaplasia in a patient on vemurafenib.
Topics: Acitretin; Aged; Biopsy; Cell Proliferation; Drug Eruptions; Eccrine Glands; Epithelial Cells; Humans; Indoles; Keratolytic Agents; Male; Melanoma; Metaplasia; Skin Neoplasms; Sulfonamides; Treatment Outcome; Vemurafenib | 2015 |
Acitretin for treatment of EGFR inhibitor-induced cutaneous toxic effects.
Topics: Acitretin; Administration, Oral; Diagnosis, Differential; Drug Administration Schedule; Drug Eruptions; ErbB Receptors; Erlotinib Hydrochloride; Female; Humans; Keratolytic Agents; Middle Aged; Pancreatic Neoplasms; Protein Kinase Inhibitors; Quinazolines | 2008 |
Treatment of psoriasis in patients with hepatitis C virus infection.
Topics: Acitretin; Antiviral Agents; Cyclosporine; Drug Eruptions; Hepatitis C, Chronic; Humans; Immunosuppressive Agents; Interferon-alpha; Methotrexate; Psoriasis; Ribavirin | 2011 |
Imatinib-associated lichenoid eruption: acitretin treatment allows maintained antineoplastic effect.
Topics: Acitretin; Aged; Antineoplastic Agents; Benzamides; Drug Eruptions; Humans; Imatinib Mesylate; Keratolytic Agents; Lichenoid Eruptions; Male; Middle Aged; Piperazines; Pyrimidines | 2006 |
Multiple milia during treatment with acitretin for mycosis fungoides.
Topics: Acitretin; Adult; Drug Eruptions; Hair Diseases; Humans; Male; Mycosis Fungoides; Skin Neoplasms | 1993 |